Enteral Nutrition Safety and Outcomes of Patients with COVID-19 on Continuous Infusion of Neuromuscular Blockers: A Retrospective Study

CONCLUSION: In COVID-19 patients on NMBA infusion for ARDS, EN was provided early at low doses for most patients, and gastrointestinal intolerance was uncommon in proned and nonproned patients, occurred at a higher rate after discontinuing NMBAs and was associated with worse outcomes. Our study suggests that EN was tolerated and safe in this patient population.PMID:37415869 | PMC:PMC10322618 | DOI:10.1155/2023/8566204

Source: Journal of Nutrition and Metabolism - July 7, 2023 Category: Nutrition Authors: Hasan M Al-Dorzi Reem Yaqoub Reema Alalmaee Ghafran Almutairi Allulu Almousa Leen Aldawsari Source Type: research